Paradigm Biocapital Advisors LP

Holdings History for Janux Therapeutics, Inc. - Common Stock (JANX)

Symbol: JANX on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 2,920,258 shares
Security Ownership %: 4.9%

Shares, Excluding Options vs Price

Value, Excluding Options

Paradigm BioCapital Advisors LP ownership in Janux Therapeutics, Inc. Common Stock (JANX)

14 Aug 2025 - Paradigm BioCapital Advisors LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,920,258 shares of Janux Therapeutics, Inc. Common Stock (JANX). This represents 4.9% ownership of the company. In their previous filing dated 14 Feb 2025, Paradigm Biocapital Advisors LP had reported owning 3,515,986 shares, indicating a decrease of +17%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Paradigm BioCapital Advisors LP	4.9%	-18%	$73,444,489	2,920,258	-595,728	-17%	$25.15	13G/A	30 Jun 2025	14 Aug 2025, 16:31
Paradigm BioCapital Advisors LP	6%		$112,757,671	3,515,986			$32.07	13G/A	31 Dec 2024	14 Feb 2025, 16:41

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		-2.1%	$0	0	-2,920,258	-100%	$13.80	Q4 2025
30 Sep 2025	2.1%	0%	$71,371,106	2,920,258	0		$24.44	Q3 2025
30 Jun 2025	2.9%	-0.4%	$67,457,960	2,920,258	-409,651	-12%	$23.10	Q2 2025
31 Mar 2025	4.1%	-0.23%	$89,907,543	3,329,909	-186,077		$27.00	Q1 2025
31 Dec 2024	6.5%	+2.1%	$188,245,890	3,515,986	+1,115,412	+46%	$53.54	Q4 2024
30 Sep 2024	3.8%	+1.3%	$109,058,077	2,400,574	+836,122	+53%	$45.43	Q3 2024
30 Jun 2024	2.5%	+2.3%	$65,534,894	1,564,452	+1,564,452	NEW	$41.89	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.